USA FINANCIAL FORMULAS’s Gilead Sciences GILD Stock Holding History

USA FINANCIAL FORMULAS’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$50.3K	Buy	+398	New	+$52.4K	0.01%	278

Other funds holding GILD

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

USA FINANCIAL FORMULAS's GILD Position: Q2 2026 in Review

USA FINANCIAL FORMULAS opened a new position in Gilead Sciences (GILD) in Q2 2026: 398 shares worth $50.3K. The stake represents 0.01% of the portfolio and ranks #278 among its holdings.

1,223 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

USA FINANCIAL FORMULAS held 398 shares of Gilead Sciences worth $50.3K as of Q2 2026.
Gilead Sciences was a new USA FINANCIAL FORMULAS position in Q2 2026.
Gilead Sciences made up 0.01% of USA FINANCIAL FORMULAS's portfolio in Q2 2026, its #278 holding.
1,223 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on USA FINANCIAL FORMULAS's 13F filing for Q2 2026, filed 4 Aug 2026.